|
 |
FortovaseThis page contains recent news articles, when available, and an overview of Fortovase but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Fortovase (when available) Saquinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Saquinavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. HIV-1 with advanced immunodeficiency together with antiretroviral nucleoside analogues Mechanism Of Action: Saquinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. News Articles on Saquinavir IAC: HIV Care Guidelines Expand Treatment Eligibility - Aug 3, 2008 ...and saquinavir (Fortovase, Invirase). The suggested nRTI combinations are tenofovir/emtricitabine (Viread/Emtriva) and abacavir/lamivudine (Ziagen/3TC). MedPage Today, Roche Farmacéutica se retira de la investigación en antirretrovirales - Jul 16, 2008 En 1995 llegó el primer inhibidor de la proteasa (IP) de la historia, saquinavir, que luego fue reformulado como Fortovase. Justo después salía al mercado LaSalud.com.mx, A Plan for Living a Long and Healthy Life (Part 2) - May 6, 2008 ...nisoldipine (Sular), and possibly verapamil (Isoptin, Verelan), Human immunodeficiency virus (HIV) protease inhibitors such as saquinavir (Fortovase, Natural News.com, Roche Continues Solid Sales Growth in First Quarter of 2008 - Both ... - Apr 17, 2008 Global sales of the HIV medicines Invirase/Fortovase (saquinavir) increased 2% to 47 million Swiss francs in the first quarter, driven by strong growth PharmaLive.com (press release), Record Operating Results for Roche Again in 2007 - Jan 30, 2008 Roche’s HIV medicines Fuzeon (enfuvirtide) and Invirase/Fortovase (saquinavir) recorded steady growth throughout 2007. In October the European Commission PharmaLive.com (press release), Photosensitive medicines listed - Aug 23, 2007 ...norfloxacin (Noroxin); ofloxacin (Floxin); oxytetracycline (Terramycin); pyrazinamide ritonavir (Norvir); saquinavir (Fortovase, Invirase); Biloxi Sun Herald, The Tale of the Evil Grapefruit - Jul 18, 2007 Blogger News Network...anti immune system drugs (cyclosporine/Sandimmune, tacrolimus/Prograf), and some HIV medicines (Fortovase, but not most of the others). AIDS and HIV Infection - Jun 26, 2007 KNDO/KNDU,RTV) Abbott Laboratories Saquinavir (Fortovase, SQV) Invirase Hoffmann-La Roche Fusion Inhibitors Enfuvirtide (Fuzeon, T-20) Hoffmann-La Roche, Philanthropic Roche shares manufacturing technology with Africa - Jun 4, 2007 In-PharmaTechnologist.com,Invirase and Fortovase (saquinavir) saw a 28 per cent increase to 182m Swiss francs (€110m), as a result of an increase in the use of the recently Roche Posts Strong First Quarter Sales – Upgrade of Core Earnings ... - Apr 18, 2007 PharmaLive.com (press release),Sales of the HIV medicine Fuzeon increased by 12%, and Invirase/Fortovase by 23%. CellCept sales rose by 7% and remained the top-selling branded YM BioSciences Strengthens Program Management of Lead Drugs - Apr 5, 2007 Drug Newswire (press release),La-Roche Inc. with leadership responsibility through NDA filings and certain of the approvals for Xeloda(TM), Fortovase(TM), Zenapax(TM), Xenical(TM). NGN Capital's Managing General Partner Georg Nebgen Joins Javelin ... - Dec 11, 2006 American Digital Networks (press release),...from F. Hoffmann-La Roche, where he led as Technical Project Leader global research & development team activities for Invirase/Fortovase. Panacos Announces New Board Member Oct 27, 2006 ...was Medical Director for Hoffmann-LaRoche's Virology Group, where he was involved in the launch of INVIRASE and developed FORTOVASE, protease inhibitors for ... -PharmaLive.com (press release), Roche AIDS drug may be pulled out of India Aug 10, 2006 ...the wholly-owned subsidiary of Swiss drug maker F Hoffmann-La Roche & Co (Roche), is likely to withdraw its anti-HIV AIDS drug Fortovase (Saquinavir) from the ... -Financial Express Roche to put AIDS drug off Indian shelves Aug 10, 2006 After withdrawing its HIV AIDS drug from Europe, Roche India is likely to discontinue manufacturing the Fortovase (Saquinavir) from the Indian market as well ... -Myiris.com Large analysis shows benefits of starting treatment with efavirenz Aug 22, 2006 The boosted protease inhibitors included were amprenavir (Agenerase), lopinavir (Kaletra), saquinavir (Invirase / Fortovase) and indinavir (Crixivan): newer ... -Aidsmap Roche To Stop Selling Protease Inhibitor Fortovase Because of ... Feb 8, 2006 15 it will stop selling its protease inhibitor Fortovase -- known generically as saquinavir -- in the US because of decreased demand for the drug and increased ... - Kaiser network.org, Roche discontinues marketing of anti-HIV drug Fortovase Feb 8, 2006 Following through on plans announced in late 2005, drugmaker Roche on Monday halted US sales of its HIV protease inhibitor Fortovase, citing low demand for the ... - The Advocate, Roche to Focus Resources on Availability of Invirase, Now ... Feb 6, 2006 February 6, 2006 -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase®, the soft ... - DG News Roche to Focus Resources on Availability of INVIRASE(R), Now ... Feb 6, 2006 6 /PRNewswire/ -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase(R), the soft ... - International News Service, Roche to Focus Resources on Availability of INVIRASE(R), Now ... Feb 6, 2006 ...- Company Voluntarily Ceases Sale and Distribution of Fortovase(R) In the US - NUTLEY, NJ, Feb. 6 /PRNewswire/ -- Roche today announced ... - PR Newswire, UPDATE 1-Roche to discontinue US sales of AIDS drug Feb 6, 2006 YORK, Feb 6 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Monday it will discontinue US sales of its HIV drug Fortovase as another ... - Reuters Roche to discontinue HIV treatment Feb 8, 2006 Swiss drug manufacturer Roche is to discontinue US sales of its HIV protease inhibitor Fortovase, a soft-gel formulation of the active ingredient saquinavir. ... - Pharmaceutical Business Review Roche discontinues marketing of anti-HIV drug Fortovase 09 Feb 2006 Following through on plans announced in late 2005, drugmaker Roche on Monday halted US sales of its HIV protease inhibitor Fortovase, citing low demand for the ... - The Advocate Roche to discontinue HIV treatment 09 Feb 2006 Swiss drug manufacturer Roche is to discontinue US sales of its HIV protease inhibitor Fortovase, a soft-gel formulation of the active ingredient saquinavir. ... - Pharmaceutical Business Review Roche To Stop Selling Protease Inhibitor Fortovase Because of ... Feb 8, 2006 15 it will stop selling its protease inhibitor Fortovase -- known generically as saquinavir -- in the US because of decreased demand for the drug and increased ... - Kaiser network.org Roche to Focus Resources on Availability of Invirase, Now ... Feb 6, 2006 February 6, 2006 -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase®, the soft ... - DG News Roche to Focus Resources on Availability of INVIRASE(R), Now ... Feb 6, 2006 6 /PRNewswire/ -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase(R), the soft ... - International News Service UPDATE 1-Roche to discontinue US sales of AIDS drug Feb 6, 2006 YORK, Feb 6 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Monday it will discontinue US sales of its HIV drug Fortovase as another ... - Reuters Roche to Focus Resources on Availability of INVIRASE(R), Now ... Feb 6, 2006 ...- Company Voluntarily Ceases Sale and Distribution of Fortovase(R) In the US - NUTLEY, NJ, Feb. 6 /PRNewswire/ -- Roche today announced ... - PR Newswire Brand Names/Synonyms: Fortovase is also known by the following brand names and/or synonymsFortovase; Invirase; ROC; SAQUINAVIR; SQV; Saquinavir; Saquinavir Mesylate; Saquinavir [Usan] Drug Category: Fortovase is categorized under the following by the FDA: Anti-HIV Agents; Anti-HIV Agents; ATC:J05AE01 Dosage Forms: INVIRASE (saquinavir mesylate) capsules and FORTOVASE (saquinavir) soft gelatin capsules Absorption: Absolute bioavailability of saquinavir administered as INVIRASE averaged 4% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: N-[1-benzyl-2-hydroxy-3-[3-(tert-butylcarbamoyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinolin-2-yl]-propyl]-2-quinolin-2-ylcarbonylamino-butanediamide : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |